A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples